Three quarters of a mile from civilization

Views, analysis & commentary - essentially on venture capital & pharmaceutical industry

Showing posts with label Repositioning. Show all posts
Showing posts with label Repositioning. Show all posts
Sunday, November 10, 2013

So what's wrong if your drug-candidate is likely better-off as a dietary-supplement?

›
In a case-study , the Nov '13 issue of HBR showcases the dilemma of a R&D head grappling with the prospect of a failing clinical p...
›
Home
View web version
Powered by Blogger.